In breast cancers, ELF3 shows high expression (Chang et al., 1997), plays an oncogenic role by promoting EMT (Schedin et al., 2004) and forms a positive feedback loop with Her2 to maintain the transformation phenotype of Her2+ breast cancers (Neve et al., 2002). This evidence concerns the gene ELF3 and breast cancer.